Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 03:59:59 2024-02-29 pm EST 5-day change 1st Jan Change
385.5 USD -0.28% Intraday chart for Intuitive Surgical, Inc. -0.91% +14.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
In risky space business, Intuitive Machines sets sights on second moon landing RE
In risky moon business, Intuitive Machines sets sights on second moonshot RE
Intuitive Surgical Insider Sold Shares Worth $325,786, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $31,418,468, According to a Recent SEC Filing MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking... Our Logo
Which Jerome will we get? Our Logo
ANALYST RECOMMENDATIONS : GM, Verizon, Fortinet, Microsoft, AMD... Our Logo
Intuitive Surgical Insider Sold Shares Worth $11,004,743, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $1,598,298, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $2,478,032, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $740,405, According to a Recent SEC Filing MT
Raymond James Raises Price Target on Intuitive Surgical to $435 From $372, Keeps Outperform Rating MT
Citigroup Raises Price Target on Intuitive Surgical to $428 From $390, Keeps Buy Rating MT
Evercore ISI Adjusts Price Target on Intuitive Surgical to $385 From $335, Keeps In Line Rating MT
Baird Raises Price Target on Intuitive Surgical to $440 From $380, Keeps Outperform Rating MT
Mizuho Adjusts Price Target on Intuitive Surgical to $390 From $350, Keeps Neutral Rating MT
Global markets live: EasyJet, Netflix, AT&T, eBay, Apple... Our Logo
Stifel Adjusts Price Target on Intuitive Surgical to $420 From $360, Maintains Buy Rating MT
Deutsche Bank Adjusts Intuitive Surgical Price Target to $370 From $275, Maintains Hold Rating MT
Truist Securities Increases Price Target on Intuitive Surgical to $435 From $390, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Intuitive Surgical to $375 From $330, Maintains Equal-Weight Rating MT
Barclays Hikes Price Target on Intuitive Surgical to $430 From $385, Maintains Overweight Rating MT
BTIG Raises Price Target on Intuitive Surgical to $412 From $392, Maintains Buy Rating MT
JPMorgan Raises Price Target on Intuitive Surgical to $475 From $325, Maintains Overweight Rating MT
Piper Sandler Raises Intuitive Surgical Price Target to $425 From $325, Maintains Overweight Rating MT
Chart Intuitive Surgical, Inc.
More charts
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (56.5%): primarily wrist cuffs; - sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.5%). The United States accounts for 66.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
385.6 USD
Average target price
408.5 USD
Spread / Average Target
+5.93%
Consensus
  1. Stock
  2. Equities
  3. Stock Intuitive Surgical, Inc. - Nasdaq
  4. News Intuitive Surgical, Inc.
  5. Intuitive Surgical Insider Sold Shares Worth $303,574, According to a Recent SEC Filing
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW